Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reparative Therapy in Acute Ischemic Stroke with Allogeneic Mesenchymal Stem Cells from Adipose Tissue
2011-003551-18Phase 2Active
- Sponsor
- FIBHULP
- Start
- Dec 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allogeneic mesenchymal stem cells from adipose tissue in ischemic stroke (2 arms), sponsored by FIBHULP. Primary endpoint: Safety. Started Dec 2011; status: active.
02
Drugs
allogeneic mesenchymal stem cells from adipose tissue
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2011-003551-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003551-18.